Regeneration Peptides: BPC-157, TB-500 & GHK-Cu at a Glance
BPC-157, full-length Thymosin Beta-4 (TB-500) and GHK-Cu are investigated in different preclinical models. This overview explains their structures, the state of research and methodological differences between single compounds and combinations.
What Are Regeneration Peptides?
Regeneration peptides are research peptides studied in preclinical research around tissue regeneration, angiogenesis (formation of new blood vessels), and cellular repair mechanisms. The best-known include BPC-157, TB-500, and the copper peptide GHK-Cu.
The compounds differ in structure and investigated mechanism: BPC-157 is a pentadecapeptide, our TB-500 is full-length synthetic Thymosin Beta-4 with 43 amino acids, and GHK-Cu is a copper-binding tripeptide. The TB-500 component is not a short fragment.
BPC-157 — the Repair Pentadecapeptide
BPC-157 (Body Protection Compound) is a synthetic 15-amino-acid peptide. Published investigations are predominantly preclinical and include angiogenesis as well as tendon, connective-tissue and cellular models.
In our range: BPC-157 as a pure solo peptide, with batch-specific analytical documentation. Background in the article BPC-157.
TB-500 — Thymosin Beta-4
Our TB-500 synthetically reproduces full-length mature Thymosin Beta-4 with 43 amino acids. Natural Thymosin Beta-4 is investigated in preclinical research in connection with cell migration, actin regulation and tissue regeneration.
In our range: TB-500 as a pure solo peptide. Background in the article TB-500.
BPC-157 + TB-500 — the Stack
A blend permits combined exposure to BPC-157 and full-length Thymosin Beta-4. Whether interactions, additivity or synergy occur must be tested in the specific model using single-compound and control groups and cannot be assumed.
In our range: BPC-157 + TB-500 Blend (BPC-157 + TB-500 stack). A comparison of both is in the article BPC-157 & TB-500.
GHK-Cu — the Copper Tripeptide
GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine with copper). Preclinical research studies it in a different field from BPC-157 and TB-500: in the context of skin regeneration, collagen synthesis, and wound-healing models.
In our range: GHK-Cu 50 mg. Background in the article GHK-Cu.
Which Regeneration Peptide for Which Research?
In short: BPC-157 for gastric, tendon, and connective-tissue models, TB-500 for cell migration and actin regulation, BPC-157 + TB-500 Blend for combined regeneration research, and GHK-Cu for skin and collagen models.
Purity & Quality — Across the Board
For reproducible research, characterization and material must fit the protocol. Our Lab Reports page lists documents currently published for specifically identified batches; results are not transferable to other batches.
They ship as a lyophilized powder that is reconstituted in the lab with bacteriostatic water.
Products and Batch-Specific Documentation
The catalogue lists BPC-157, TB-500 as full-length Thymosin Beta-4, the BPC-157 + TB-500 blend, and GHK-Cu. Published analytical reports apply only to the specifically identified sample or batch.
FAQ on Regeneration Peptides
What are regeneration peptides?
Research peptides studied in preclinical research around tissue regeneration, angiogenesis, and cellular repair. The best-known are BPC-157, TB-500, and GHK-Cu.
What is the difference between BPC-157 and TB-500?
BPC-157 is a 15-amino-acid peptide; our TB-500 is full-length synthetic Thymosin Beta-4 with 43 amino acids and not a short fragment. Both are investigated in different preclinical research models.
Can BPC-157 and TB-500 be combined?
In research the two are frequently combined because they address different mechanisms. We offer this as a ready stack in a single vial: BPC-157 + TB-500 Blend.
Are regeneration peptides intended for human use?
No. All regeneration peptides mentioned here are intended exclusively for laboratory research and are not approved as medicines for human use.
Disclaimer: Research peptides are offered exclusively for research purposes. They are not intended for human use. This page provides neutral scientific orientation and does not constitute medical claims or therapeutic promises.